Eaglenos Co., Ltd., established in 2017, brings together top talents in chemistry, materials, electronics, software, machinery, biomedical engineering and other fields. Adhering to the core values of "quality, innovation, cooperation and accountability", Eaglenos is committed to the innovation in electrochemistry, microfluidics, signal acquisition and automation technologies. We have launched a series of accurate POCT products for various diseases such as diabetes, hyperuricemia, cardiovascular and cerebrovascular diseases.Eaglenos started its formal operation in June 2018 and has continuously expanded and developed. With an investment of 150 million RMB, the company has an R&D base of over 9,000 square meters in Nanjing Jiangbei New Area, including international standard R&D labs, GMP production workshops and automated production lines, etc. Throughout the years, we have gradually established three product platforms, including cartridge testing, strip testing and continuous monitoring. We believe that it is our responsibility to continuously enrich our product line of precision testing, provide high-quality health management products and services to the world, and become the guardian of human health.

Lead G2M Digital Business Transformation for UCB International Markets.

Our mission is to deliver transformative value to people living with neurological, immunological and bone conditions by maximizing the impact of UCB’s medicines through innovative technological solutions which are readily applicable via the healthcare delivery system. Disease category leadership provides UCB the best position to develop a holistic understanding of how the digital revolution will unlock the creation of new types of patient value delivered via new partnership combinations. Through external connectivity, network, and partnership development the Patient Relevant Innovative Solutions Mission (PRISM) activates the health technology ecosystem to deliver meaningful innovation and strengthen our category leadership. We shape the future of care through the integration of new innovative technological solutions, data assets and algorithms with differentiated science to improve patient outcomes, accelerate the evolution of new treatment approaches and ultimately enable each individual patient to live the life they choose. We pioneer new patient value models through external engagement while creating, testing, and improving new solutions for patients and their caregivers. Our hands-on experience with these new solutions in combination with deep knowledge of external advances in neurotech enable us to guide UCB decisions, both incremental and radical, to drive our collective patient value ambitions.

WeDoctor Group - Chinese online healthcare solutions platform, the first and largest Internet hospital (Wuzhen Internet Hospital).Responsible for overall Commercial Insurance business in WeDoctor Group.Led the China first ACO Commercial Insurance product - the first Internet Healthcare insurance product.Led the WeDoctor HMO products.Led the commercial insurance TPA big data and AI products for hospitals and insurance companies.

Private hospital businessPharmaco collaboration business

Led the development, integration and acceleration of Multi-Channel Marketing in China, working closely with global and local stakeholders to drive strategic and innovative multi-channel initiatives to further support China-specific objectives. Partner with brand teams to integrate new channels into traditional sales and marketing to deliver great interactions to customers. Make business impact by increasing frequency and coverage in an innovative, strategic, cost effective and low compliance risk way.Multi-Channel Marketing capabilities include: . Call Center channel - Telesales, Telemarketing, Patient Support . Digital Marketing – Brand Digital Communication Strategy and Plan, Mobile Healthcare Solutions, B2C/ePharmacy, Digital Content Management, Closed Loop Marketing, iPad based Interactive Detailing . Strategic Collaboration Projects - Partner with government, association, university to deliver Continued Medical Education, Hospital Head Forum, and Hospital Medical Checkup Center Programs.. Channel Integration, Multi-Channel Marketing Campaign, Integrated Customer Experience. Commercial Modeling, Channel Effectiveness

Responsible for AstraZeneca China Commercial IT Capability Management, including: Field Force Mobility, Digital Marketing, SFE/CRM, ERP, BI/DW, Financial systems, SharePoint, BPM, HR, etc.

Asiapac project manager for Global Travel & Expense Program - Key part of global Finance Fast Forward initiative. - >10M RMB investment, ~10,000 users, 14 countries/regions - >20 internal team members, 3 vendors, 15 external team members

- Business Partnership Management- Information Services Strategic Planning and Portfolio Management - Information Services Project Management

- Pacific IT Leader, Specialty Film & Sheet, GE Advanced Materials - Shanghai, PRC- Global Manufacturing IT Project Leader, GE Advanced Materials – Pittsfield, MA USA - Network Project Leader, GE Advanced Materials – Shanghai, PRC- Greater China ERP Implementation Project Leader, GE Advanced Materials – Shanghai, PRC